Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation

Introduction. Mucinous adenocarcinoma of the prostate is a rare variant of prostate cancer. Its malignant potential and the clinical course of the affected patients remain, by and large, controversial. No data exist about the course of metastatic mucinous adenocarcinoma of the prostate. Case Present...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalaitzis, Christos, Koukourakis, Michael, Giannakopoulos, Stilianos, Giatromanolaki, Alexandra, Sivridis, Efthimios, Bantis, Athanasios, Touloupidis, Stavros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926244/
https://www.ncbi.nlm.nih.gov/pubmed/24600526
http://dx.doi.org/10.1155/2014/218628
_version_ 1782303943647297536
author Kalaitzis, Christos
Koukourakis, Michael
Giannakopoulos, Stilianos
Giatromanolaki, Alexandra
Sivridis, Efthimios
Bantis, Athanasios
Touloupidis, Stavros
author_facet Kalaitzis, Christos
Koukourakis, Michael
Giannakopoulos, Stilianos
Giatromanolaki, Alexandra
Sivridis, Efthimios
Bantis, Athanasios
Touloupidis, Stavros
author_sort Kalaitzis, Christos
collection PubMed
description Introduction. Mucinous adenocarcinoma of the prostate is a rare variant of prostate cancer. Its malignant potential and the clinical course of the affected patients remain, by and large, controversial. No data exist about the course of metastatic mucinous adenocarcinoma of the prostate. Case Presentation. This case report describes the excellent clinical course of a 68-year-old patient with metastatic mucinous adenocarcinoma of the prostate, treated by radical prostatectomy, irradiation, and androgen deprivation. Conclusion. In our case, mucinous adenocarcinoma of the prostate does not appear to behave differently than acinar prostate cancer. Its malignant potential is dependent on its Gleason score.
format Online
Article
Text
id pubmed-3926244
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39262442014-03-05 Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation Kalaitzis, Christos Koukourakis, Michael Giannakopoulos, Stilianos Giatromanolaki, Alexandra Sivridis, Efthimios Bantis, Athanasios Touloupidis, Stavros Case Rep Urol Case Report Introduction. Mucinous adenocarcinoma of the prostate is a rare variant of prostate cancer. Its malignant potential and the clinical course of the affected patients remain, by and large, controversial. No data exist about the course of metastatic mucinous adenocarcinoma of the prostate. Case Presentation. This case report describes the excellent clinical course of a 68-year-old patient with metastatic mucinous adenocarcinoma of the prostate, treated by radical prostatectomy, irradiation, and androgen deprivation. Conclusion. In our case, mucinous adenocarcinoma of the prostate does not appear to behave differently than acinar prostate cancer. Its malignant potential is dependent on its Gleason score. Hindawi Publishing Corporation 2014 2014-01-29 /pmc/articles/PMC3926244/ /pubmed/24600526 http://dx.doi.org/10.1155/2014/218628 Text en Copyright © 2014 Christos Kalaitzis et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kalaitzis, Christos
Koukourakis, Michael
Giannakopoulos, Stilianos
Giatromanolaki, Alexandra
Sivridis, Efthimios
Bantis, Athanasios
Touloupidis, Stavros
Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
title Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
title_full Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
title_fullStr Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
title_full_unstemmed Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
title_short Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation
title_sort metastatic mucinous adenocarcinoma of the prostate with psa value of 8.6 ng/ml at 5-year-followup after prostatectomy, radiotherapy, and androgen deprivation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926244/
https://www.ncbi.nlm.nih.gov/pubmed/24600526
http://dx.doi.org/10.1155/2014/218628
work_keys_str_mv AT kalaitzischristos metastaticmucinousadenocarcinomaoftheprostatewithpsavalueof86ngmlat5yearfollowupafterprostatectomyradiotherapyandandrogendeprivation
AT koukourakismichael metastaticmucinousadenocarcinomaoftheprostatewithpsavalueof86ngmlat5yearfollowupafterprostatectomyradiotherapyandandrogendeprivation
AT giannakopoulosstilianos metastaticmucinousadenocarcinomaoftheprostatewithpsavalueof86ngmlat5yearfollowupafterprostatectomyradiotherapyandandrogendeprivation
AT giatromanolakialexandra metastaticmucinousadenocarcinomaoftheprostatewithpsavalueof86ngmlat5yearfollowupafterprostatectomyradiotherapyandandrogendeprivation
AT sivridisefthimios metastaticmucinousadenocarcinomaoftheprostatewithpsavalueof86ngmlat5yearfollowupafterprostatectomyradiotherapyandandrogendeprivation
AT bantisathanasios metastaticmucinousadenocarcinomaoftheprostatewithpsavalueof86ngmlat5yearfollowupafterprostatectomyradiotherapyandandrogendeprivation
AT touloupidisstavros metastaticmucinousadenocarcinomaoftheprostatewithpsavalueof86ngmlat5yearfollowupafterprostatectomyradiotherapyandandrogendeprivation

Ejemplares similares